awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37076243-FD80A45F-C830-49F5-9B37-3E0B64DB58EF
Q37076243-FD80A45F-C830-49F5-9B37-3E0B64DB58EF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37076243-FD80A45F-C830-49F5-9B37-3E0B64DB58EF
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.
P2860
Q37076243-FD80A45F-C830-49F5-9B37-3E0B64DB58EF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37076243-FD80A45F-C830-49F5-9B37-3E0B64DB58EF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
906c506e18b0b9f82a3bf04f8f481fd7f5a69b7a
P2860
Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort stu